Deliver Consulting Limited | Back to main site

Speaker Short Biography

  • Johannes Nippgen

    Head of R&D Biopharma

    Merck Group (China)

    Short Biography

    Johannes Nippgen, MD, PhD, is Head of R&D Biopharma in China for Merck. He passionately aspires to innovation and improvement and strives towards bringing healthcare R&D in China to global leadership. After studying Medicine in Mainz, Germany,  and earning his doctorate in Wurzburg, Germany, Johannes started his professional career as surgical oncologist. He holds German and European board certifications in Urology/ GU-oncology and published in various regional and international journals including the New England Journal of Medicine.Seeking for more opportunities in clinical development he joined Merck KGaA in 2004 as Medical Leader, where he took responsibility for early development compounds and assumed roles with increasing responsibility in the pivotal development of Erbitux®. After Erbitux® approvals for mCRC and SCCHN in various regions with Merck KGaA, Johannes helped Imclone Systems build its ex-US-hub in Germany, establishing global clinical development capabilities as Associate Vice President Medical Sciences. In this position he was responsible for early global clinical development including meanwhile approved compounds. When Eli Lilly was acquiring Imclone, Johannes assumed in addition the role as Chair of the ImClone/Lilly joint Tumor Advisory Council for Genito-Urinary malignancies. After leaving Imclone, he took responsibility as Chief Medical Officer and Head of Clinical Development at Glycotope in Berlin, Germany, leading the transition from a research based to a clinical biotech with 4 compounds in clinical development, followed by a short affiliation with Karyopharm Inc. in Boston, US. In January 2016 Johannes re-joined Merck KGaA in Germany, reassuming the R&D lead role for Erbitux® to ensure success of the pivotal development programs in China. Since January 2018, Johannes holds the position of Vice President, Head of R&D, Merck Biopharma China and is based in Beijing.